Pacira Pharmaceuticals, Inc.

Parsippany-Troy Hills, NJ Federal

UEI
S29KQL4CCNA9
CAGE
61QS0
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
5 Sylvan Way #300, Parsippany, NJ 07054, USA
Website
pacira.com
Founded
2007
Employees
251-1K
Estimated annual revenue
$100M-$250M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract vehicles

Contract awards

Similar vendors

About the company

Pacira Pharmaceuticals, Inc. is a pharmaceutical company focused on the development, manufacture and commercialization of pharmaceutical products, based on its DepoFoam extended release drug delivery technology, for use primarily in hospitals and ambulatory surgery centers. The company has been registered in the System for Award Management (SAM.gov) to receive federal awards since 2010.

Through federal contracts, Pacira Pharmaceuticals has provided the Department of Veterans Affairs with its IoVera handheld cryotherapy devices for operative care procedures. These contracts, awarded by the Veterans Health Administration's Veterans Integrated Service Networks 17 and 19 in 2020 and 2019 respectively, facilitated the purchase of the IoVera systems to support pain management during surgical operations at VA medical facilities. The contracts were competitively awarded with no set-asides used.

Pacira Pharmaceuticals currently holds a Federal Supply Schedule contract with the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. Awarded in September 2022, this multiple award indefinite-delivery/indefinite-quantity (IDIQ) contract has a potential value of over $93 million over five years to procure drugs, pharmaceuticals, and hematology related products under Schedule 65 IB. No set-aside was designated for this procurement vehicle aimed at ensuring a steady supply of medications and specialized treatments to support healthcare services for the over 9 million Veterans enrolled annually across the VA's integrated network. As the prime contractor, Pacira Pharmaceuticals is responsible for delivering the contracted pharmaceutical products efficiently through established price lists and individual task orders issued by VA medical centers within the network.

Quick answers

Is Pacira Pharmaceuticals, Inc. registered in SAM.gov?

Yes. Pacira Pharmaceuticals, Inc.'s SAM.gov registration is active through August 14, 2027.

Which contract vehicles does Pacira Pharmaceuticals, Inc. hold?

Pacira Pharmaceuticals, Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.

What is Pacira Pharmaceuticals, Inc.'s most recent federal award?

Pacira Pharmaceuticals, Inc.'s most recent federal contract award is Purchase of iovera hand held devices for operative care (36C25620P1285), from Veterans Integrated Service Network 16 (VHA), on August 7, 2020.

On GovTribe

See Pacira Pharmaceuticals, Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors